PT - JOURNAL ARTICLE AU - Picard, Rick AU - Osthus, Dave TI - Forecast Intervals for Infectious Disease Models AID - 10.1101/2022.04.29.22274494 DP - 2022 Jan 01 TA - medRxiv PG - 2022.04.29.22274494 4099 - http://medrxiv.org/content/early/2022/05/01/2022.04.29.22274494.short 4100 - http://medrxiv.org/content/early/2022/05/01/2022.04.29.22274494.full AB - Forecast intervals for infectious disease transmission and mortality have long been overconfident — i.e., the advertised coverage probabilities of those intervals fell short of their subsequent performances. Further, there was no apparent relation between how good models claimed to be (as measured by their purported forecast uncertainties) and how good the models really were (as measured by their actual forecast errors). The main cause of this problem lies in the misapplication of textbook methods for uncertainty quantification. A solution lies in the creative use of predictive tail probabilities to obtain valid interval coverages. This approach is compatible with all probabilistic predictive models whose forecast error behavior does not change “too quickly” over time.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was developed with the support of LANL's Laboratory Directed Research and Development projects 20200698ER and 20190546ECR.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesForecast data are accessible from https://covid19forecasthub.org/